Reports Summarize Chronic Hepatitis Research from University of Texas McGovern Medical School (Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice).
In: Hepatitis Weekly, 2024-03-11, S. 823-823
serialPeriodical
Zugriff:
A recent study conducted by researchers at the University of Texas McGovern Medical School has found that the probiotic Limosilactobacillus reuteri DSM 17938 can have anti-inflammatory effects in mice with chronic hepatitis. The study focused on mice with a genetic mutation that causes immune dysregulation and Treg deficiency, similar to a condition called IPEX syndrome in humans. The researchers observed that the probiotic treatment led to a reduction in hepatic inflammation and changes in lipid profiles associated with autoimmune disease. These findings suggest that probiotics may contribute to the reduction of lipids by reducing inflammatory pathways. [Extracted from the article]
Copyright of Hepatitis Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Reports Summarize Chronic Hepatitis Research from University of Texas McGovern Medical School (Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice).
|
---|---|
Zeitschrift: | Hepatitis Weekly, 2024-03-11, S. 823-823 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1086-0223 (print) |
Sonstiges: |
|